你好! Shipping to Taiwan with premium packaging for just NT$300 

Ship to
Taiwan
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada Biosimilars and Interchangeable Biologics: Tactical Elements
Type
Physical Book
Publisher
Language
English
Pages
624
Format
Paperback
ISBN13
9781032652344
Edition No.
1

Biosimilars and Interchangeable Biologics: Tactical Elements

Sarfaraz K. Niazi (Therapeutic Proteins International Llc Chicago Illinois Usa) (Author) · Crc Press · Paperback

Biosimilars and Interchangeable Biologics: Tactical Elements - Sarfaraz K. Niazi (Therapeutic Proteins International Llc Chicago Illinois Usa)

Cheaper New Book Imported to Taiwan
Delivery: 24 Sep - 07 Oct Shipping: 18 to 22 business days.
NT$ 2,150
Faster New Book Imported to Taiwan
Delivery: 04 Sep - 14 Sep Shipping: 4 to 5 business days.
NT$ 3,134
NT$ 2,150

Synopsis "Biosimilars and Interchangeable Biologics: Tactical Elements "

What's the Deal with Biosimilars?Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Tactical Elements explores the development and manufacturing of biosimilars and targets challenges surrounding the creation of these products. This includes manufacturing, production costs, and intellectual property barriers, particularly in regulated markets (regulatory agencies are still in the process of developing guidelines). It addresses the complexity of biological drugs, and it discusses specific structural elements vital to the functionality, immunogenicity, and safety of biosimilar products.Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume provides an overall understanding of the hurdles, difficulties, and practicalities of developing a strong plan. It introduces a step-by-step approach for creating a strategy that helps develop and manufacture a biosimilar product while reducing overall production costs and meeting the requirements of biosimilarity based on analytical and functional, pharmacokinetic, pharmacodynamic (where applicable), and nonclinical toxicology or toxicokinetic similarity (where appropriate) while remaining competitive in the market.

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews